GSS.AX实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 13:59):

Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa...

Stats
今日成交量	219 028
平均成交量	119 514
市值	131.47M
EPS	$0 ( 2024-02-19 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-5.87
ATR14	$0.00900 (1.28%)

Genetic Signatures Ltd 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Genetic Signatures Ltd 财务报表

Annual	2023
营收:	$16.94M
毛利润:	$-12.74M (-75.21 %)
EPS:	$-0.0957

FY	2023
营收:	$16.94M
毛利润:	$-12.74M (-75.21 %)
EPS:	$-0.0957

FY	2022
营收:	$35.42M
毛利润:	$7.21M (20.36 %)
EPS:	$0.0209

FY	2021
营收:	$28.28M
毛利润:	$18.48M (65.34 %)
EPS:	$0.0169

Financial Reports:

No articles found.

Genetic Signatures Ltd

Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name. The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. In addition, it offers detection kits for gastrointestinal infections, respiratory, sexual health, anti-microbial resistance, meningitis, and tropical disease. The company was incorporated in 2001 and is headquartered in Newtown, Australia.